← FDA DRUG APPROVALS

FDA ANDA · ANDA075094

RANITIDINE HYDROCHLORIDE

Sponsor: CONTRACT PHARMACAL

APPLICATION
ANDA075094
TYPE
ANDA
ORIGINAL APPROVAL
1999-06-21
LATEST ACTION
2000-09-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

RANITIDINE HYDROCHLORIDEDiscontinued
RANITIDINE HYDROCHLORIDE EQ 75MG BASE · TABLET · ORAL

Approval history

2000-09-21Manufacturing (CMC) · Supplement 9AP
2000-01-06Manufacturing (CMC) · Supplement 1AP
1999-06-21OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →